What is the latest price of tucatinib/tucatinib in 2024?

Tucatinib is approved along with trastuzumab and capecitabine to treat a certain type of hormone receptor-positive breast cancer that has spread to other parts of the body and is not treatable with surgery in adults who have already been treated with at least one other chemotherapy drug. Tucatinib is also used with trastuzumab to treat a certain type of colorectal cancer (cancer that starts in the large intestine) that has spread to other parts of the body and cannot be treated with surgery in adults who have been treated with other chemotherapy drugs and have not improved or gotten worse.

Tucatinib belongs to the kinase inhibitor class of drugs. It prevents cancer cells from multiplying by blocking the action of abnormal proteins. This helps stop or slow the spread of cancer cells. Tucatinib is available as an oral tablet. It is usually taken twice daily with or without food, about 12 hours apart. Patients took tucatinib at approximately the same time each day.

It is understood that the original drug of tucatinib has not yet been launched in China, so it is not eligible for medical insurance. The European version of Tucatinib's original drug specification 150mg*60 tablets sold overseas may cost more than 70,000 per box (the price may fluctuate due to the exchange rate), which is very expensive. Generic drugs of tucatinib are currently on the market for sale overseas. For example, the price of 150mg*30 tablets produced by a Bangladesh pharmaceutical factory is more than 4,000 yuan (the price may fluctuate due to the exchange rate). The price is much cheaper than the original drug, and the ingredients of foreign generic drugs are basically the same as the original drug. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.